IR信息FY2022 Second Quarter Financial Results Presentation Materials

IR信息FY2022 Second Quarter Financial Results Presentation Summary of Q&A Session

IR信息新愿景与下期经营计划“Mission 2030”说明资料

IR信息关于制定新愿景与下期经营计划 “Mission 2030” 的通知

IR信息FY2022 Second Quarter Summary of Consolidated Financial Statements

信息U.S. EPA’s Review of the Toxicity Assessment of Chloroprene Monomers (6th Report)

信息Portfolio Reforms through Withdrawal from Cement Business and Restructuring of Carbide Chain

IR信息Notice Regarding Transfer of Cement Sales Business to a Wholly Owned Subsidiary through Company Split (Simplified Absorption-Type Company Split), Transfer of Shares in the Wholly Owned Subsidiary (Changes in Subsidiaries) and Withdrawal from Cement Busine

IR信息Notice Regarding Revisions to Consolidated Results Forecasts for the First Half and the Full Year of the Fiscal Year Ending March 31, 2023 and Posting of Extraordinary Losses

信息Denka Publishes the Integrated Report, Denka Report 2022

信息New release of QuickNavi™-Noro 3, a Rapid Antigen Test for Norovirus, on October 26 in Japan — Higher Sensitivity to Various Genotypes —

信息Denka Collaborates with U.S.-based Epicore Biosystems, Inc., Aiming to Create a New Healthcare Business — Starting Verification for the Commercialization of Wearable Sweat Patch Sensors for the Japanese and Asian Markets —

IR信息FY2022 First Quarter Financial Results Presentation Summary of Q&A Session

IR信息FY2022 First Quarter Financial Results Presentation Materials

IR信息FY2022 First Quarter Summary of Consolidated Financial Statements

信息Denka Completes High-Efficiency Gas Turbine Power Generators at Chiba Plant ~ Environmental Investment of Around 3.7 Billion Yen Boosts Cost Competitiveness and Cuts CO2 Emissions at Least 12 Kilotons per Year ~

信息U.S. EPA’s Review of the Toxicity Assessment of Chloroprene Monomers (5th Report)

IR信息Notice of Convocation of the 163rd Ordinary General Meeting of Shareholders

IR信息FY2021 Financial Results Presentation Summary

IR信息FY2021 Financial Results Presentation Topics (Healthcare Business)

IR信息FY2021 Financial Results Presentation Materials

IR信息FY2021 Summary of Consolidated Financial Statements

信息U.S. EPA’s Review of the Toxicity Assessment of Chloroprene Monomers (4th Report)

信息决定通过约110亿日元的战略投资增强包括抗原检测试剂在内的检测试剂产品生产能力

信息The Impact of the Situation between Russia and Ukraine on Our Business

信息New Hydroelectric Power Plant Begins Operations, Expanding the Use of Clean Energy ~ Commercial Operation of New Himekawa No. 6 Power Plant Commences ~

信息Denka Concludes Mizuho Positive Impact Finance Agreement with Mizuho Bank, Ltd.

信息Denka Decides on the Construction of Chemical Recycling Plant for Used Polystyrene Resins ～Aiming to Build a Carbon-free, Resource Circulating Society by Reusing Waste Plastic to Achieve the SDGs～

信息新年贺词